leadf
logo-loader
viewElixinol Wellness Ltd
(
ASX:EXLOTCQB:ELLXFFRA:E8M
)

Elixinol Global substantial holder Regal Funds Management increases stake

The company recently increased its share purchase plan from the initial A$2 million target to around A$12.3 million to accommodate strong shareholder demand.

Elixinol Global Ltd - Elixinol Global substantial holder Regal Funds Management increases stake
Elixinol is pursuing new growth opportunities.

Elixinol Global Ltd's (ASX:EXL) (OTCMKTS:ELLXF) (FRA:E8M) substantial holder Regal Funds Management Pty Ltd has increased its stake in the company from 8.32% to 10.17%.

Regal has accumulated the new shares via a series of transactions between January 20, 2021 and February 3, 2021.

Oversubscribed share purchase plan

In December 2020, Elixinol significantly increased the size of its share purchase plan (SPP) from the initial A$2 million target to around A$12.3 million to accommodate strong shareholder demand after it was significantly oversubscribed.

The company received applications totalling around A$27.2 million for the SPP, which closed on December 11, 2020.

Funds raised from the SPP, together with the A$8.2 million from the recent placement, will be used to execute the company’s strategy and pursue new growth opportunities.

Quick facts: Elixinol Wellness Ltd

Follow
ASX:EXL

Price: 0.105 AUD

Market Cap: $33.12 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Elixinol Wellness feeling increasingly positive after 'significantly...

  Elixinol Wellness Ltd (ASX:EXL, OTCQB:ELLXF, FRA:E8M)'s Oliver Horn speaks to Proactive following the news of a 53% improvement in EBITDA on the previous corresponding period - its best earnings result since the first half of 2019. Horn says they've continued to deliver on its strategy to...

on 18/8/21

2 min read